1h Free Analyst Time
The gene therapy market is forecasted to grow by USD 6.73 billion during 2023-2028, accelerating at a CAGR of 23.31% during the forecast period. The report on the gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in special drug designations, benefits associated with gene therapy, and increasing prevalence of chronic diseases.
The gene therapy market is segmented as below:
By Delivery Mode
- In vivo
- Ex vivo
By Therapy Area
- Oncology
- CNS
- Ophthalmology
- Rare diseases
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the gene therapy market covers the following areas:
- Gene therapy market sizing
- Gene therapy market forecast
- Gene therapy market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Delivery Mode
7 Market Segmentation by Therapy Area
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global gene therapy market: Abeona Therapeutics Inc, Adaptimmune Therapeutics PLC, Adverum Biotechnologies Inc, Amgen Inc., Astellas Pharma Inc., Biogen Inc., bluebird bio Inc., Editas Medicine Inc., ElevateBio, F. Hoffmann La Roche Ltd., Generation Bio Co., Gilead Sciences Inc., Novartis AG, Orchard Therapeutics PLC, Poseida Therapeutics Inc., Sangamo Therapeutics Inc, Sibiono GeneTech Co. Ltd., Syncona Ltd., uniQure NV, and Voyager Therapeutics Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing research in gene therapy for CVDs and orphan diseases."
According to the report, one of the major drivers for this market is the increase in special drug designations.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abeona Therapeutics Inc
- Adaptimmune Therapeutics plc
- Adverum Biotechnologies Inc
- Amgen Inc.
- Astellas Pharma Inc.
- Biogen Inc.
- bluebird bio Inc.
- Editas Medicine Inc.
- ElevateBio
- F. Hoffmann La Roche Ltd.
- Generation Bio Co.
- Gilead Sciences Inc.
- Novartis AG
- Orchard Therapeutics Plc
- Poseida Therapeutics Inc.
- Sangamo Therapeutics Inc
- Sibiono GeneTech Co. Ltd.
- Syncona Ltd.
- uniQure NV
- Voyager Therapeutics Inc
